Dalbavancin, Oritavancin and Tedizolid Are Safe and Effective for Skin Infection Treatment

Archives of Clinical Infectious Diseases- Iran

doi 10.5812/archcid.22065

Full Text

Abstract

Available in

Date

Authors

Publisher

Kowsar Medical Institute

Related search

In Vitro Activity of Tedizolid and Dalbavancin Against MRSA Strains Is Dependent on Infection Source

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2019English

In Vitro Activity of Tedizolid, Dalbavancin, and Ceftobiprole Against Clostridium Difficile

Frontiers in Microbiology
Microbiology
2018English

Oritavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections: An Evidence-Based Review

Core Evidence
MedicineReviewsReferencesPharmacology
2015English

Are Generic Immunosuppressants Safe and Effective?

British Medical Journal
Medicine
2015English

Systematic Review and Network Meta-Analysis of Tedizolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection (Absssi) Due to Methicillin-Resistant Staphylococcus Aureus (Mrsa)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Real-World Experience With Dalbavancin Therapy in Gram-Positive Skin and Soft Tissue Infection, Bone and Joint Infection

Infection
MedicineInfectious DiseasesMicrobiology
2019English

Dalbavancin and Wound Healing: New Evidences/Insights in a Mouse Model of Skin Infection.

2019English

Autologous and Allogeneic Marrow Stromal Cells Are Safe and Effective for the Treatment of Acute Kidney Injury

Stem Cells and Development
Developmental BiologyHematologyCell Biology
2009English

Is "Safe Effective Glucose Control" Effective and Safe?

Critical Care
Critical CareIntensive Care Medicine
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy